• Nenhum resultado encontrado

LATERAL FLOW ASSAY FOR CRYPTOCOCCAL ANTIGEN: AN IMPORTANT ADVANCE TO IMPROVE THE CONTINUUM OF HIV CARE AND REDUCE CRYPTOCOCCAL MENINGITIS-RELATED MORTALITY

N/A
N/A
Protected

Academic year: 2019

Share "LATERAL FLOW ASSAY FOR CRYPTOCOCCAL ANTIGEN: AN IMPORTANT ADVANCE TO IMPROVE THE CONTINUUM OF HIV CARE AND REDUCE CRYPTOCOCCAL MENINGITIS-RELATED MORTALITY"

Copied!
8
0
0

Texto

Imagem

Fig. 1 - A. Schematic showing operation of lateral flow immunochromatographic assay for  detection of cryptococcal antigen
Fig. 3 - A proposal of an algorithm for clinical implementation of cryptococcal antigen  screening and targeted preemptive therapy for the prevention of cryptococcal meningitis

Referências

Documentos relacionados

Sendo um processo da gamification no jornalismo online, os Newsgames utilizam a mecânica e elementos de jogos no contexto de notícia para informar, gerar

FIGURE 2 : Distribution of Cryptococcus neoformans and Cryptococcus gattii molecular types in the cities of Mato Grosso do Sul according to the place of residence of the

CSF cryptococcal antigen titers are positive in 90% of non-AIDS patients, but se- rum cryptococcal antigen is detected in only 50% of cases.. Cryptococcal cultures of CSF may be

Objective: To verify the relationship between intracranial pressure and flash visual evoked potentials (F-VEP) in patients with cryptococcal meningitis.. Method: The sample

The neurological manifestations directly related to HIV are acute viral meningitis, chronic meningitis, HIV-associated dementia (HAD), vacuolar myelopathy, and involvement of

The frequency of both intravenous drug abuse and cocaine/crack use in this patient population also contributes to other potential causes of cerebral infarctions,

In this review, we highlight the importance of: (1) earlier HIV diagnosis and HAART initiation with retention-in-care to avoid AIDS; (2) pre-HAART cryptococcal antigen (CRAG)

In this study, patients who were treated for at least 2 weeks (IP) were evaluated and, for patients who continued until a cure or a change of treatment using other antifungal